ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,574Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 2170

$863K Total Retail Price of All Prescriptions

Rank: 117 out of 2170

487 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 15,263 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 643 578 1 4
OMEPRAZOLE 568 487 2 2
ATORVASTATIN CALCIUM 530 481 3 12
SIMVASTATIN 512 482 4 1
LEVOTHYROXINE SODIUM 459 417 5 5
LOSARTAN POTASSIUM 429 386 6 21
METFORMIN HCL 388 355 7 8
CRESTOR 379 344 8 24
POTASSIUM CHLORIDE 379 363 8 16
LISINOPRIL 365 339 10 3
WARFARIN SODIUM 360 349 11 15
METOPROLOL TARTRATE 340 302 12 10
CHLORTHALIDONE 339 324 13 166
METOPROLOL SUCCINATE 332 317 14 13
HYDROCODONE-ACETAMINOPHEN 309 271 S3 15 7
GLIMEPIRIDE 228 214 16 31
CITALOPRAM HBR 223 213 17 19
FUROSEMIDE 219 199 18 6
ZOLPIDEM TARTRATE 210 180 19 17
PRAVASTATIN SODIUM 207 204 20 11
LOSARTAN-HYDROCHLOROTHIAZIDE 184 184 21 42
NEXIUM 168 168 22 22
TAMSULOSIN HCL 158 158 23 33
COUMADIN 158 149 23 163
PANTOPRAZOLE SODIUM 143 132 25 39
TORSEMIDE 141 141 26 184
ISOSORBIDE MONONITRATE ER 136 136 27 50
CARVEDILOL 132 129 28 26
RAMIPRIL 131 118 29 77
SYNTHROID 128 119 30 27
PREDNISONE 126 105 31 41
BENAZEPRIL HCL 125 124 32 55
DONEPEZIL HCL 122 122 33 32
LIPITOR 121 112 34 83
PROAIR HFA 120 105 35 43
DILTIAZEM ER 116 111 36 133
DILTIAZEM 24HR CD 116 108 36 82
GLIPIZIDE 116 98 36 62
ALLOPURINOL 114 106 39 29
AMLODIPINE BESYLATE-BENAZEPRIL 113 103 40 67
CYMBALTA 107 92 41 44
PAROXETINE HCL 107 107 41 65
SPIRONOLACTONE 104 94 43 71
LOVASTATIN 100 100 44 34
GABAPENTIN 100 94 44 14
CLOPIDOGREL 100 92 44 37
BISOPROLOL-HYDROCHLOROTHIAZIDE 99 97 47 116
DIOVAN 97 82 48 53
TRAMADOL HCL 90 87 49 18
JANUVIA 89 73 50 80
KLOR-CON M20 86 80 51 68
ENALAPRIL MALEATE 86 80 51 64
CELEBREX 84 75 53 89
RANITIDINE HCL 83 75 54 40
VENLAFAXINE HCL ER 81 69 55 97
MIRTAZAPINE 81 79 55 46
BYSTOLIC 81 81 55 138
FLUOXETINE HCL 81 78 55 59
FLUTICASONE PROPIONATE 79 75 59 30
OXYCODONE-ACETAMINOPHEN 77 57 S2 60 60
PLAVIX 76 66 61 58
FENOFIBRATE 75 75 62 57
ROPINIROLE HCL 73 72 63 92
MECLIZINE HCL 72 72 64 134
HYDROCHLOROTHIAZIDE 71 71 65 9
BUSPIRONE HCL 68 68 66 143
SPIRIVA 67 57 67 49
JANUMET 66 53 68 249
FINASTERIDE 66 66 68 122
COMBIVENT 63 54 70 112
TERAZOSIN HCL 61 61 71 156
AZITHROMYCIN 61 53 71 47
DEXILANT 60 55 73 199
LEVOXYL 59 47 74 115
NIASPAN 59 58 74 103
POLYETHYLENE GLYCOL 3350 58 54 76 63
ADVAIR DISKUS 53 44 77 45
NASONEX 53 52 77 285
ZETIA 52 51 79 78
SERTRALINE HCL 52 36 79 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 46 81 20
TRICOR 50 49 81 130
DIGOXIN 50 39 81 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.